One Health Conference 2024 - Speaker Bios
Speaker Bios - One Health Conference 2024
Combating Antimicrobial Resistance with Stewardship
Elizabeth S. Dodds Ashley, PharmD, MHS
Elizabeth S. Dodds Ashley, PharmD, MHS, is a Professor of Medicine and Operations Director for the Duke Antimicrobial Stewardship Outreach Network (DASON) based at Duke University. She has been an active antimicrobial stewardship pharmacist for more than 20 years. Her work and research in stewardship span a variety of patient care settings including large academic medical centers, community hospitals and long-term care facilities. She is a current liaison member and first pharmacist on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) representing SIDP. She is actively involved in several professional societies engaged in stewardship including SHEA and SIDP for which recently served as President.
Julia E. Szymczak, PhD
Julia E. Szymczak, PhD is an Associate Professor at the University of Utah School of Medicine, where she Co-Directs the Utah Quality Advancement Laboratory. Dr. Szymczak is a medical sociologist with expertise in the social dynamics that shape healthcare delivery. She conducts federally funded research on patient safety and healthcare quality improvement, with a specific focus on infectious diseases. Her current work examines the social determinants of antimicrobial prescribing, developing novel interventions and policies to improve the use of these drugs to preserve their long-term effectiveness.
Jennifer Granick, DVM, MS, PhD, Dipl. ACVIM (SAIM), Associate Professor
Dr. Granick is an associate professor of small animal internal medicine at the University of Minnesota College of Veterinary Medicine. She received her D.V.M. from the University of Wisconsin, completed a small animal internal medicine residency at the University of Minnesota, and a Ph.D. in Comparative Pathology from the University of California. She co-chairs the World Small Animal Veterinary Association's Therapeutics Committee, is a member of the American Veterinary Medical Association's Committee on Antimicrobials and co-directs the University of Minnesota's Antimicrobial Resistance and Stewardship Initiative. Her research focuses on antimicrobial use and multidrug resistant infection surveillance in companion animals.
Stephen Cole, VMD, MS, DACVM
Stephen Cole (he/him) is a Diplomate of the American College of Veterinary Microbiologists, and his specialties include clinical bacteriology/mycology and antimicrobial therapy. He is the Director of Penn Vet’s Clinical Infectious Disease Laboratory. Dr. Cole’s research focuses on combating the spread of antimicrobial resistance (AMR) between people and animals. His work characterizes the clinical and molecular epidemiology of AMR in pets and defines best practices for antimicrobial stewardship. He developed and leads Penn Vet’s innovative Of Clouds and Clocks course and teaches bacteriology, diagnostics and antibiotic pharmacology. He has received numerous teaching awards and is a AAVMC One Health Scholar.
Stephanie Chang, PharmD
Dr. Stephanie Y. Chang is an antimicrobial stewardship/infectious diseases clinical pharmacist at Northwestern Medicine Huntley, McHenry, and Woodstock Hospitals. Dr. Chang earned a Bachelor of Science degree in chemistry from the University of Illinois at Urbana-Champaign in 2011 and a Doctor of Pharmacy degree from University of Illinois at Chicago in 2015. She went on to complete a PGY-1 pharmacy practice residency at Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana and PGY-2 infectious diseases specialty residency at Dell Seton Medical Center at the University of Texas in Austin, Texas. Her work is focused on the area of antimicrobial stewardship and clinical interests include rapid diagnostic testing and treatment of multi-drug-resistant infections.
Michelle Funk, DVM, MPH
Dr. Michelle Funk is a veterinarian by training with a Masters in Public Health (concentration in Epidemiology). After 10 years of clinical practice, she joined the Chicago Department of Public Health in 2021, where is currently the Medical Director of Healthcare and Congregate Settings within the Disease Control Bureau. In her current role, she supports infection control and outbreak response for higher risk settings, such as shelters, corrections, healthcare facilities, and schools. She also serves on the Council of State and Territorial Epidemiologists One Health Antimicrobial Resistance Surveillance Task Force and the APIC Veterinary Infection Prevention and Control Working Group.
Michael Klepser, PharmD
Dr. Michael Klepser, PharmD is a professor of pharmacy at the Ferris State College of Pharmacy. He is also the founder and Senior Director of CHARM. CHARM is a program that partners with human and animal health systems to collect outpatient antimicrobial data and report prescribing patterns among humans and partner animals. CHARM provides partners with interactive dashboards to identify areas for antimicrobial stewardship initiatives.
Jeffrey Linder MD, MPH, FACP
Dr. Jeffrey A. Linder, MD, MPH, FACP is a general internist and primary care clinician-investigator. Dr. Linder is the Michael A. Gertz Professor of Medicine and the Chief of the Division of General Internal Medicine at the Northwestern University Feinberg School of Medicine. Dr. Linder’s research focuses on the care of ambulatory patients with acute respiratory infections (ARIs) – the number one symptomatic reason for seeking medical care in the United States – and the appropriate use of antibiotics in ambulatory care. Dr. Linder has expertise in electronic health records and clinical decision support as well as using behavioral science and social psychology to understand and change behavior. Dr. Linder served on the “Outpatient Antibiotic Use Target-Setting Workgroup” which was convened by the Centers for Disease Control and Prevention and The Pew Charitable Trusts; the Antibiotic Stewardship Research Workshop Planning Committee of the Society for Healthcare Epidemiology of America; and has served on advisory or expert committees for the National Committee on Quality Assurance, The Joint Commission, and the Infectious Diseases Society of America. Dr. Linder received his medical degree from Northwestern University, did a Fellowship in General Medicine and Primary Care at Massachusetts General Hospital, and has a Masters of Public Health degree from the Harvard TH Chan School of Public Health.
Michael Lin MD, MPH
Michael Lin, MD, MPH, is an infectious diseases physician and Professor of Medicine at Rush University Medical Center in Chicago, Illinois. He serves as Hospital Epidemiologist for Rush University Medical Center and is a co-investigator with the CDC Prevention Epicenters Program. His research focuses on the epidemiology of healthcare-acquired infections and on implementing surveillance and infection prevention measures in healthcare facilities.
Shane Zelencik MPH, CIC, LTC-CIP
Shane Zelencik has his Master of Public Health, is certified in Infection Prevention and Control (CIC), Long Term Care Infection Prevention and Control (LTC-CIP), is a Fellow in the Association for Professionals in Infection Control and Epidemiology (FAPIC), and is a certified Project Management Professional (PMP). He has worked in infection control for 15 years in Acute Care Hospitals, Ambulatory Clinics, Long Term Care Facilities, Assisted Living, Dialysis, Home Care, and Public Health. He currently serves as Senior Infection Preventionist and Projects Administrator for the Chicago Department of Public Health and leads the Project Firstline and Acute Care, Outpatient, and Other (ACHOO) teams within the Healthcare Settings program.
